Results 61 to 70 of about 38,036,070 (284)

Lisch Nodules in Neurofibromatosis Type 1

Pediatric Neurology Briefs, 1991
The prevalence of Lisch nodules among 167 patients with neurofibromatosis 1 is reported from the Department of Pediatrics, Genetics Division, Miami Children’s Hospital, Miama, FL.
J Gordon Millichap
doaj   +1 more source

Health Supervision for Children With Neurofibromatosis Type 1

Pediatrics, 2019
Neurofibromatosis type 1 (NF1) is a multisystem disorder that primarily involves the skin and peripheral nervous system. Its population prevalence is approximately 1 in 3000.
David T. Miller, D. Freedenberg, E. Schorry, N. Ullrich, D. Viskochil, B. Korf   +5 more
semanticscholar   +1 more source

Quality of life in patients with neurofibromatosis type 1 and 2 in Canada

Neuro-Oncology Advances, 2020
Background There is scarce data on the quality of life of people with neurofibromatosis type 1 (NF1) and type 2 (NF2) in Canada. Methods A cross-sectional study of adults with NF1 and NF2 attending a tertiary center.
Geohana Hamoy-Jimenez, R. Kim, S. Suppiah, G. Zadeh, V. Bril, C. Barnett   +5 more
semanticscholar   +1 more source

Bone and Soft Tissue Neoplasms in Infants Versus Older Children: A Report From the Cancer in Young People in Canada Program

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background and Aims Infant bone and soft tissue neoplasms present distinct clinical challenges and lack large‐scale data to inform treatment decisions. This study aims to characterize bone and soft tissue neoplasms in infants in Canada and to compare their outcomes with those of older pediatric patients.
Samuel Sassine, Hallie Coltin, Maria Kondyli, Monia Marzouki, Nicolas Prud'homme, Nida Usmani, Rebecca J. Deyell, Lesleigh Abbott, Tony H. Truong, Sapna Oberoi, Ketan Kulkarni, Josée Brossard, Lynette Bowes, Paul Gibson, Sarah McKillop, Roona Sinha, Lillian Sung, Catherine Vezina, Laura Wheaton, Alexandra P. Zorzi, Marie‐Claude Pelland‐Marcotte, Thai Hoa Tran   +21 more
wiley   +1 more source

A multicenter study of neurofibromatosis type 1 utilizing deep learning for whole body tumor identification

npj Digital Medicine
Deep-learning models have shown promise in differentiating between benign and malignant lesions. Previous studies have primarily focused on specific anatomical regions, overlooking tumors occurring throughout the body with highly heterogeneous whole-body
Cheng-Jiang Wei, Yan Tang, Yang-Bai Sun, Tie-Long Yang, Cheng Yan, Hui Liu, Jun Liu, Jing-Ning Huang, Ming-Han Wang, Zhen-Wei Yao, Ji-Long Yang, Zhi-Chao Wang, Qing-Feng Li   +12 more
doaj   +1 more source

Learning Disabilities in Neurofibromatosis Type 1

Pediatric Neurology Briefs, 2006
The frequency of specific leaning disabilities (SLD) in neurofibromatosis type 1 (NF1) was determined in a cohort of 81 patients (43 males, 38 females; mean age 11 years 6 months; age range 8-16) followed at Children's Hospital, Westmead, NSW, Australia.
J Gordon Millichap
doaj   +1 more source

Organoids in pediatric cancer research

FEBS Letters, EarlyView.
Organoid technology has revolutionized cancer research, yet its application in pediatric oncology remains limited. Recent advances have enabled the development of pediatric tumor organoids, offering new insights into disease biology, treatment response, and interactions with the tumor microenvironment.
Carla Ríos Arceo, Jarno Drost
wiley   +1 more source

Vascular Abnormalties in Neurofibromatosis Type 1

Pediatric Neurology Briefs, 2005
The spectrum of cerebrovascular abnormalities (CVA), including moyamoya, was evaluated in a retrospective chart review of 353 patients with neurofibromatosis type 1 (NF1) seen at the Children’s National Medical Center, Washington, DC, from 1995 to 2003.
J Gordon Millichap
doaj   +1 more source

An update on the central nervous system manifestations of neurofibromatosis type 1

Acta Neuropathologica, 2019
Neurofibromatosis 1 (NF1) is an autosomal dominant genetic disorder that presents with variable phenotypes as a result of mutations in the neurofibromatosis type 1 ( NF1 ) gene and subsequently, abnormal function of the protein product, neurofibromin ...
J. S. Nix, J. Blakeley, Fausto J. Rodriguez   +2 more
semanticscholar   +1 more source

Evaluating discrepancies between high‐yield neuroscience conditions in preclerkship medical education and national clinical incidence

Anatomical Sciences Education, EarlyView.
Abstract Medical education must balance foundational science with clinical relevance. Increasing emphasis on standardized assessments has led to prioritization of “high‐yield” conditions—those most likely to be assessed. Subsequently, educators and students often prioritize these conditions.
Kathryn Veazey, Oheneba Boadum
wiley   +1 more source